We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
AusPAR: Human Papillomavirus Vaccine Types 16 and 18 (recombinant, AS04 adjuvanted)
Australian Public Assessment Report
Device/Product Name
Cervarix
Active ingredients
Human Papillomavirus Vaccine Types 16 and 18 (recombinant, AS04 adjuvanted)
AusPAR Date
Published
Submission Number
PM-2009-02655-3-2
Submission Type
Major variation (extension of indications)